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Abstract 
Untethered actuation is important for many robotic devices to achieve autonomous motion, 
which is typically enabled by using batteries. However, this results in extra weight for the 
device and the need to regularly recharge the battery. Using enzymes to provide the required 
electrical charge is particularly interesting as it will enable faster recharging and direct 
harvesting of fuel components from a surrounding fluid. The latter is an advantage towards 
applications in implantable and ingestible devices and environmental monitoring of aqueous 
environments containing metabolizable carbon. Here, we present a soft artificial muscle that 
uses biofuels (glucose and oxygen) to drive the actuator. Enzymes integrated in the actuator 
catalytically convert glucose and oxygen into electrical power that in turn is converted into 
movement by the electroactive polymer polypyrrole causing the actuator to bend. Aspergillus 
niger glucose oxidase enzyme combined with tetrathiafulvalene 7,7,8,8-
tetracyanoquinodimethane (TTF/TCNQ) and laccase enzyme from Trametes versicolor with 
2,2′-azinobis-(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS) formed the integrated 
bioelectrode pair. The performance of the glucose/O2 bioelectrode pair showed a maximum 
open circuit voltage of 0.70 0.04 V at room temperature and a maximum power density of 
0.27 μW cm−2 at 0.50 V, enough to drive an external polypyrrole-based trilayer artificial 
muscle. Next the enzymes were fully integrated into the artificial muscle, resulting in an 
autonomously powered actuator that could bend reversibly in both directions driven by glucose 
and O2 only. This autonomously powered artificial muscle could be of great interest for soft 
(micro-)robotics and implantable or ingestible medical devices that need to manoeuvre 
throughout the body, for devices in regenerative medicine (tissue culture), for wearables, and 
to allow environmental monitoring devices to operate autonomously in aqueous (and possibly 
certain gaseous) environments. 
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1. Introduction 
Autonomous movement is an essential capability in living organisms. It allows the individual 
species to grasp and manipulate objects, as well as to move, to escape danger, find food, or 
meet other individuals. Nature has developed various means that enable movement and 
locomotion, from protein motors that drive cilia to specialised muscle tissue, all autonomous 
and self-powered. In mammalian muscles, glucose and oxygen (O2) are consumed to generate 
adenosine triphosphate (ATP) by aerobic respiration. The ATP, being converted to adenosine 
diphosphate (ADP) due to hydrolysis, in turn drives the nanoscopic conformational changes in 
the myosin heads with respect to the actin filaments that cause the macroscopic muscle 
contraction and elongation.1 In contrast, human-made contraptions such as industrial or 
humanoid robots are typically driven by classical actuators that use electrical, pneumatic, or 
thermal means and are often tethered or require large batteries. Driving actuators, or artificial 
muscles, directly using biofuels such as glucose, is highly anticipated. It would enable (soft) 
robotic devices to be fuelled by green, biofuels such as glucose, methane or alcohol and open 
up possibilities for driving implants or injectable vehicles in the body without the need for 
batteries or external charging sources such as by radiofrequency (RF) coils.  
Analogous to the mammalian muscles, we demonstrate here artificial, polymer muscles driven 
by glucose and O2. Soft, artificial muscles have been reported based on dielectric elastomers,
2 
conducting polymers,3,4 carbon nanotubes5,6 and even fishing lines7 and textiles,8 but they still 
all are driven by electrical or thermal means. Conducting polymer artificial muscles are 
interesting as they are operated at low voltages and behave similarly to mammalian muscle. 
During oxidation and reduction, conducting polymers change their volume - as well as other 
material properties such as colour (electrochromism)9, wettability10 and adhered protein 
conformation11 - which is used to construct actuators. The volume change is based on the 
dimensional changes that occur as a result of electrochemically induced ion insertion and 
desertion, along with associated solvating species,12,13 accompanied by conformational 
changes in polymeric chains.14 Artificial muscles based on conducting polymers come in many 
configurations, one of which is the so-called trilayer or bimorph configuration (Fig. 1A), which 
we use here to demonstrate the principle. The conducting polymer, e.g. polypyrrole (PPy) or 
poly(3,4-ethylenedioxythiophene) (PEDOT), is sandwiched on two sides of a flexible 
membrane.15,16 A potential difference is applied between the two conducting polymer layers, 
electrochemically oxidizing the conducting polymer on one side and reducing the conducting 
polymer on the other side. This causes one layer to shrink and the other to swell, thus resulting 
in a bending motion. However, these artificial muscles are still driven by an external, often 
tethered electrical power source. Direct conversion of chemical energy into electrical energy 
to drive these biomimetic machines would be the most elegant solution and would capitalise 
on the efficiencies already achieved by nature. Catalysts such as enzymes can achieve such 
direct conversion and are, for instance, integrated in bioelectrodes. Coupled as a pair such 
bioelectrodes can form a biofuel cell which can generate electrical power from biofuels.17 The 
power output of biofuel cells can drive microdevices that need relatively low power.18 
Bioelectrodes that convert Glucose and O2 respectively are particularly interesting as they 
enable autonomous power generation in physiological fluids because glucose is present in all 
organs, thus eliminating the need to pump fuel. Also O2 is present in all organs, thus removing 
the need for air supply through a membrane at the cathode compartment.19 Several research 
groups have used glucose as a biofuel. For example, Mano and Heller reported biological 
motion in presence of glucose and oxygen to move a carbon fibre using glucose oxidase (GOx) 
and bilirubin oxidase to create a H+ flux that drove the fibre.20 Movement of carbon nanotubes 
was achieved by using GOx and catalase to generate hydrogen peroxide which in turn was 
catalysed into O2 bubbles that propelled the nanotubes.
21 Miyake et al. report a biofuel cell that 
used fructose and O2 as fuels.
22 It was prepared by modifying fructose dehydrogenase and 
bilirubin oxidase on carbon nanotube-decorated carbon fibre fabrics and could drive light-
emitting diodes. A pacemaker powered by a glucose/O2 biofuel cell was presented by 
MacVittie et al.23 Strack et al used enzymes in solution to construct a biochemical logic circuit 
to control a chemical actuator.24 However, despite these advances, artificial muscles are still 
being driven using external means.  
Here, we present a polymer artificial muscle powered by glucose and O2 biofuels in which 
enzymatic electrodes are fused with the polymer artificial muscle to create an integrated bionic 
system. The artificial muscle was based on a PPy trilayer actuator using 
dodecylbenzenesulphonate (DBS) as the dopant. A tetrathiafulvalene 7,7,8,8-
tetracyanoquinodimethane (TTF/TCNQ)/Aspergillus niger glucose oxidase enzyme modified 
Au electrode and 2,2′-azinobis-(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS)/laccase 




Glucose oxidase EC 1.1.3.4, from Aspergillus niger, laccase enzyme of Trametes versicolor, 
2,2′-azinobis-(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS), and tetrathiafulvalene 7,7,8,8-
tetracyanoquinodimethane (TTF/TCNQ) were purchased from Sigma-Aldrich. Pyrrole (from 
SAFC®, acquired through Sigma-Aldrich) was distilled under vacuum prior to use and stored 
at -20 °C. Porous poly (vinylidene fluoride) (PVDF) with 0.45 m pore size and a thickness of 
110 m (Immobilon-P) was acquired from Sigma-Aldrich, and Sodium dodecylbenzene 
sulfonate (NaDBS) was obtained from TCI, Japan. Graphite was purchased from Merck 
(Germany). D-(+)-glucose,  NH3 (98%), and H2O2 (30%) were purchased from VWR. 
Potassium phosphate dibasic anhydrous (K2HPO4), Potassium dihydrogen phosphate 
(KH2PO4), Sodium acetate and glacial acetic acid were obtained from Merck (Germany). All 
solutions were prepared using 18 M DI water (Milli-Q).  
 
2.2. Bioelectrode fabrication and characterisation 
The bioelectrodes acting as working electrodes and containing enzymes and mediators were 
prepared by immobilizing the constituent materials onto a 0.5 cm 0.5 cm Au/Si electrode. 
First, the bare Au electrode surfaces were cleaned by immersion in NH3, H2O2, and DI water 
(1:1:5) at 85°C for 10 minutes and thereafter washed gently with DI water. For the bioanodea 
                                                 
a NOTE: The definition of the cathode and anode depends on whether the system is regarded as a galvanic cell or 
electrochemical cell. Since we are combining two cell types into a fused device this definition can become 
confusing. We have used the following conventions: The bioanode is the electrode where glucose is oxidized and 
electrons are transferred into the electrode, and the biocathode is the electrode where O2 is reduced and electrons 
are transferred from the electrode (following classical biofuel cell definition). The cathode is the electrode that 
reduces PPy (by donating electrons) and the anode is the electrode that oxidizes PPy (by accepting electrons). 
preparation, 10 µL of TTF/TCNQ was drop cast on the Au electrode and dried at room 
temperature for 15 min. Then 10 L GOx enzyme solution (5 mg ml-1) was deposited onto the 
TTF-TCNQ/Au surface and gently dried under airflow in a laminar flow hood for 15 min. The 
biocathodea was prepared by pipetting 10 L of a 0.002 M ABTS solution and drying at room 
temperature for 15 min. After that, 10 L of laccase solution (5 mg ml-1) was cast on the 
ABTS/Au support and gently dried under airflow in a laminar flow hood for 15 min. For the 
bioelectrodes integrated on the artificial muscle, 10 L of reduced graphene oxide (RGO) was 
drop cast as a barrier on both sides of each bioelectrode before adding mediators and enzymes. 
The RGO was synthesized from graphite through a modified Hummers’ method 25. 
Electrochemical measurements were performed at room temperature using an Ivium 
compactstat or IviumStat Potentiostat/Galvanostat (Eindhoven, The Netherlands) in a three-
electrode electrochemical cell, which included a modified Au/Si electrode as the working 
electrode, a piece of Au/Si 3 cm  3 cm as the counter electrode and a BASi MF-2052 Ag/AgCl 
(3 M KCl) reference electrode. Cyclic voltammograms were performed in a cell containing 5 
ml of 0.1 M phosphate buffer solution (PBS), pH 5.0 at 100 mV s−1, over potential ranges from 
−0.50 V to 0.50 V for the bioanode and 0 V to 1 V for the biocathode. The electrochemical 
properties of the anodic and cathodic electrodes were obtained in the absence and presence of 
0.1 M glucose (dissolved in 0.1 M PBS) and air saturation (after 30 min bubbling air) 
respectively. 
To assess possible power generation both bioelectrodes were submerged in a beaker filled with 
20 ml of 0.1 M PBS (pH 5.0) with 0.1 M glucose and saturated with air (30 min). The electrodes 
consisted of 1 cm ×1 cm pieces of an Au coated silicon wafer. The TTF-TCNQ/GOx served as 
the bioanode for the oxidation of glucose and mediated electron transfer. The ABTS/laccase 
                                                 
Thus, the bioanode is the cathode and the biocathode the anode with respect to the electrochemical actuator and 
as used in Figures 3-5.  
served as the biocathode for reduction of O2 by mediated electron transfer. The bioanode and 
biocathode were combined thus de facto forming a classical membrane-less biofuel cell, and 
Figure 1B illustrates its mechanism. The complete cell was allowed to equilibrate at open 
circuit potential (OCP) before measurements were performed. 26  
The OCP of the bioelectrode pair was investigated over a period of 7 days. The electrodes were 
stored at room temperature and the OCP checked regularly using a potentiostat/galvanostat 
(Ivium compactstat) with a very high input impedance (>1000 GΩ). For the stability test, an 
external load of 1 M was connected between the two electrodes. The power output of the cell 
in the stability tests was calculated from the potential and resistance values according to Ohm’s 
law. 
 
2.3. Artificial muscle preparation 
For the preparation of the artificial muscle, a thin Au film was sputtered on both sides of a 
piece of PVDF membrane using a Vacutec Plasma Systems Sputter at a pressure of 4.6 mTorr, 
36.6 cm3/min Ar flow and a sputter rate of 5 nm/min for 5 min. Next, PPy was synthesized 
electrochemically on both sides of Au/PVDF/Au membrane at a +0.6 V vs Ag/AgCl, by 
immersing the membrane in a solution containing 0.1 M pyrrole and 0.1 M NaDBS. For the 
electrosynthesis, each side of Au/PVDF/Au was connected to the working electrode separately, 
a stainless-steel mesh (2 cm  7 cm) was used as the counter electrode, and the same Ag/AgCl 
reference electrode as a previous was used. A typical chronoamperogram of the PPy synthesis 
on one side of Au/PVDF/Au for 3000 seconds is shown in Supplementary Information (SI), 
Figure S1A. After PPy electropolymerisation on both sides, strips of 0.5 cm  2 cm were cut, 
resulting in PPy/Au/PVDF/Au/PPy trilayer artificial muscles27. The artificial muscles were 
actuated in 0.1 M NaDBS solution and 0.1 M PBS (pH 5.0) at room temperatures using cyclic 
voltammetry (CV) and chronoamperometry (Figs. S1B-E). CVs of the PPy/Au/PVDF/Au/PPy 
artificial muscle were taken over the potential range-1.7 V to 0.50 V (in 0.1 M NaDBS) and -
1.2 V to 0.2 V (in 0.1 M PBS, pH 5.0), in both cases with a scan rate of 20 mV s-1. The 
chronoamperometric activation of the PPy/Au/PVDF/Au/PPy artificial muscle was performed 
at a constant potential of -0.45 V (in 0.1 M NaDBS) and -0.50 V (in 0.1 M PBS, pH 5.0).  
 
2.4. Enzyme-driven artificial muscles 
The artificial muscle was fabricated integrating the enzymes in 4 different configurations to 
investigate different properties, and with increasing complexity and increasing integration. i) 
The enzymes as bioelectrodes externally connected to the artificial muscle; ii) the enzymes 
integrated on artificial muscle as a single, separated bioelectrode directly connected to each 
side of the PPy/Au/PVDF/Au/PPy actuator (i.e. bioanode on one side and biocathode on the 
other side), iii) with fully integrated enzymes on each side of the actuator, and finally iv) with 
the enzymes as a bioelectrode pair on each side, but mirrored (i.e. anode-cathode pair on one 
side and cathode-anode pair on the other side). The fabrication of the artificial muscle with the 
integrated enzyme-bioelectrodes combines the fabrication steps as described in section 2.2 and 
2.3. Sketches of the configurations are included in each figure. 
 
2.5 Artificial muscle driven by external potentiostat 
To investigate the function of artificial muscle before connecting to the external bioelectrodes, 
the motion of PPy/Au/PVDF/Au/PPy trilayer artificial muscle was surveyed using the 
potentiostat in chronoamperometric mode for 2 cycles of 0 V, for 300 s and -0.70 V for 300 s 
in two different electrolytes 0.1 M NaDBS and 0.1 M PBS (pH 5.0), respectively. The potential 
range of 0 V to -0.70 V was chosen to simulate the maximum OCP potential. After showing 
good performance of the artificial muscle movement using the potentiostat, the 
PPy/Au/PVDF/Au/PPy trilayer artificial muscle was connected to the external bioelectrodes 
and characterized. This movement experiment was run for around 4 hours.  
All the movements were recorded using a Digital Microscope (Dino-Lite AM785MZT). All 
images in Figures 3-5 are merged from two frame grabs as indicated by the dashed line. The 
original figures are found in the SI. 
 
3. Results and Discussion 
3.1. External enzyme-bioelectrodes  
First, the individual, external enzyme-bioelectrodes were investigated. Each step of the surface-
modified Au/Si electrode was verified by the CV experiments in 0.1 M PBS (pH 5.0), in the 
absence and presence of glucose with scan rate of 100 mV s-1. Figure S2A-curve a shows the 
CV obtained with the bare-Au electrode as a control experiment. The TTF-TCNQ-modified 
Au electrode produced a current of 13.14 A cm-2 at a potential of 0.16 V and this peak was 
ascribed to the redox processes of TTF-TCNQ adsorbed on the Au electrode (Fig. S2A-curve 
b).28 As shown in Figure S2A-curve c, after casting GOx enzyme on the electrode forming 
TTF-TCNQ/ GOx, the current reached to 88.8 A cm-2 at potential of 0.32 V and along with 
the increase in anodic current, there was a decrease in the cathodic peak at 0 V. After adding 
the glucose, the electrocatalytic current reached to 262 A cm-2 for 0.1 M glucose at potential 
of 0.32 V, showing that the bioanode exhibited a good bioelectrocatalytic activity for the 
oxidation of glucose (Fig. S2A- curve d).  
Figure S2B shows the CV of the biocathode under the same conditions as for the bioanode 
experiment, i.e. in 0.1 M PBS (pH 5.0), and in the absence and presence of O2 at a scan rate of 
100 mV s-1. The bare-Au electrode was investigated as a control (Fig. S2B-curve a). When the 
bare-Au electrode was modified with ABTS, the current of the ABTS/Au electrode increased 
to 16.84 A cm-2 at a potential of 0.64 V (Fig. S2B-curve b). Thereafter laccase was chemically 
bound to the ABTS/Au electrode, and the current increased to 27.15 A cm-2 at a potential of 
0.62 V (Fig. S2B-curve c). Finally, operation in the air-saturated 0.1 M PBS  (pH 5.0) showed 
an increase of the peak current to 33.31 A cm-2 at potential of 0.58 V, which was close to the 
redox potential of laccase and ABTS 29 (Fig. S2B-curve d), with well-defined cathodic waves 
attributed to the reduction of O2 by the laccase. The results indicate that laccase 
electrochemically catalysed the reduction of O2 through the mediated electron transfer reaction 
between the active centre of laccase and the electrode. 
Next, the bioelectrode pair was inserted (without a separating membrane) in a 0.1 M glucose 
and 30 min air-saturated 0.1 M PBS (pH 5.0) at room temperature. Figure 2A shows the 
polarization curves of TTF-TCNQ/GOx-modified Au electrode (curve a) and the 
laccase/ABTS-modified Au electrode (curve b). As expected, the recorded OCP of 0.70±0.04 
V corresponds to the difference between the individually measured OCPs of the bioanode (Fig. 
2A-curve a) and the biocathode (Fig. 2A-curve b). Figure 2B presents the OCP of the cell when 
the cell was operated continuously for 7 days. The cell OCP decreased by 20% per day and 
reached 0.15 V at day 7. This drop could be due to the consumption of glucose and O2. The 
variation of the power density as a function of the cell voltage presents the typical bell-shaped 
curve observed by others 30,31,  with a maximum of 0.27 W cm−2 at 0.50 V in 0.1 M PBS 
(pH 5.0) (Fig. 2C). The cell voltage under an external load of 1 M resistance, was recorded 
for 27 hours, operating in the 0.1 M PBS (pH 5.0). When the cell was operated continuously 
under this load, it lost 25% of its original power in the first 12 h and the power output dropped 
by 50% after a 27 hours continuous work. The cell voltage decreased slowly to 0.10 V (Fig. 
2D). It was observed that the bioelectrode pair retained 60% of its initial power density up to 
3 days when it was operated continuously. The decline in power density output after 3 days 
might be caused by a loss of mediators and enzymes, since they were not covalently attached 
to the electrodes. 
 
3.2. Artificial muscle driven by external bioelectrodes 
Before connecting the artificial muscle to the external enzyme-bioelectrodes, the muscle’s 
performance was checked using an external potentiostat in two different electrolytes, 0.1 M 
NaDBS and 0.1 M PBS (pH 5.0) using both CV and chronoamperometry (Figures S1B-E). As 
can be seen in Figure S3 the actuator showed the normal reversible movement as previously 
seen for such trilayer actuators, indicating that the actuator was functioning correctly. The 
movement was reduced in the physiological PBS electrolyte as compared to simple NaDBS 
salt solution, which is consistent with previous results using cerebral physiological solutions32. 
Operating at a slightly lower pH should not influence its performance.33  
Having established that the bioelectrode pair can deliver sufficient potential difference (~0.70 
V) and power to drive a trilayer actuator34 and that the actuator operated normally, we 
connected the PPy/Au/ PVDF/Au/PPy trilayer artificial muscle to the external bioelectrodes. 
As can be seen in Figure 3, the movement of artificial muscle driven by the external 
bioelectrodes is clear. At T0, the initial position, the artificial muscle was connected to the 
bioelectrodes and the muscle bent towards the anodica side as would be expected.35 On the 
anodic side PPy(DBS) was oxidised and shrank and on the cathodica side PPy(DBS) is reduced 
and swelled, thus causing a bending to the left. The position of the artificial muscle after 4 
hours is indicated by point T1 showing a 5 mm displacement. 
 
3.3 Artificial muscles with integrated catalytic bioelectrodes 
Next, we integrated the bioelectrodes on the PPy/Au/PVDF/Au/PPy trilayer artificial muscle. 
The separate bioanode was integrated at the top on one side of the actuator and likewise the 
separate biocathode was integrated at the top on the opposing side. In the integrated device we 
initially found some leakage and mixing of the bio-anode and -cathode materials through the 
porous PVDF membrane and to ensure better retention, an additional RGO layer was 
introduced as a barrier between the bio-anode and -cathode. This resulted in the required 
performance. When inserted into the glucose/O2 containing electrolyte the actuator started to 
move directly. Figure 4A shows the movement upon insertion into the glucose/O2 containing 
electrolyte. As with the external bioelectrodes, the muscle bent 2 mm towards the anode side 
demonstrating that the bio-catalytic electrodes can be integrated with the artificial muscle. 
Thereafter we fully integrated the enzymes onto the entire artificial muscle. The movement of 
the now self-powered PPy/Au/PVDF/Au/PPy artificial muscle is shown in Figure 4B. Again, 
the displacement occurred towards the anode side, moving clearly from its starting position T0 
to the final position T1 after 3 hours with a total displacement of 3 mm. Figure 4C shows the 
displacement over time of the fully integrated artificial muscle. It shows the typical 
displacement profile as seen for CP actuators which are diffusion limited, although slower than 
when driven by an external power supply. 
To check whether the actuator is truly driven by faradaic reactions at the catalytic bioelectrodes 
three control experiments were performed. First, the actuator without any bioelectrodes was 
inserted into the biofuel-containing electrolyte (Fig. S4A). Next, the actuator with the fully 
integrated bioelectrodes was inserted in DI water (Fig. S4B) and in a N2 saturated 0.1 M PBS 
(pH 5.0) (Fig. S4C), respectively, that is two solutions without any biofuel. In neither of the 
three cases any movement could be observed, indicating that indeed the movement was caused 
by the catalytic conversion of O2 and glucose.  
A single movement towards one side only has only limited applications, for instance as a single-
use valve. To be useful as self-powered artificial muscle to drive (soft robotic) devices, 
reversible movement of the actuator is required. To achieve this, we integrated an anode and 
cathode on both the top and bottom of each side of PPy/Au/PVDF/Au/PPy trilayer artificial 
muscle, but in a mirrored configuration. We inserted the integrated muscle into the solution 
while keeping the top electrode pair above the water level (i.e. inactive). As previously, the 
muscle bent towards the anode side that is to the left, displacing 2.5 mm in 3 hours (from T0 to 
T1 in Figure 5A). Next, we rotated the muscle so that the inserted electrode pair went above 
the water level and non-inserted electrode pair came under the water level thus de facto 
changing the polarity of the inserted bioelectrodes and thus reversing the electrochemical 
reactions in the PPy layers. The left side, which was now the cathode side, was reduced and 
the PPy(DBS) layer swelled and the right side, now the anode, was oxidised and shrunk. This 
resulted into a bending motion to the right, returning to the original position (from T2 to T3 in 
3 hours) as shown in Figure 5B, i.e. a reversible self-powered artificial muscle. 
 
4. Conclusions 
We have demonstrated that enzyme-based bioelectrodes that use glucose and O2 could power 
artificial muscles. The immobilization of the enzymes with redox mediators resulted a potential 
difference over the bioelectrodes of more than 0.50 V, which was sufficient to drive an 
externally connected actuator. In a glucose and air saturated 0.1 M PBS (pH 5.0), a maximum 
power density of 0.27 W cm−2 was measured at room temperature. The OCP of catalytic 
bioelectrode pair was 0.70 V 0.04 V. The stability of the bioelectrodes was tested for around 
27 hours with a load of 1 M. We then demonstrated an autonomously powered artificial 
muscle by integrating the catalytic bioelectrodes. These self-powered artificial muscles showed 
reversible motion in both directions. The bioelectrodes manufactured according to this process 
have good stability and are promising candidates to autonomously drive artificial muscles.  
In this work we demonstrated for the first time the principle of self-powered artificial muscles 
using the body’s principal biofuel.. To enhance the biofuel powered actuator performance, 
including speed,  power output stability (e.g. by improved immobilisation, engineering the 
enzymes) and the magnitude of the generated potential (as increasing the potential difference 
will increase the speed of actuation34) need to be increased, for instance by better integration 
of the enzymes and optimisation of the ratio of biocathode/anode materials and conducting 
polymer. We used the trilayer actuator configuration, which range of motion can be improved 
by optimising the actuator design (e.g. using a softer, more flexible membrane, optimising the 
ratio between the three actuator layers36) to exemplify biofuel-powered artificial muscles as a 
bending motion is clearly visible, but this is only one possible configuration of conducting 
polymer artificial muscles. The concept can be generalised to other artificial muscle 
configurations. Linear actuation8 and complex devices comprising multiple actuators4 are 
especially interesting future targets. The Laccase and Glucose Oxidase reactions might have 
asymmetric electron transfer, which could result in non-symmetric movements, which is not 
visible in trilayer actuators since the bimorph design with two identical PPy layers ensures 
symmetric deflection. To get a symmetric charge transfer one would for instance need to 
optimise the ratio between Laccase and Glucose Oxidase enzymes and/or adjust the mediators 
that assist in the charge transfer from the enzyme to the conducting polymer layer Here we 
used the body’s principal biofuel glucose, but the same concept can be extended to using other 
in vivo fuels or even other biofuels present in the environment to enable autonomous propulsion 
of robots that can “swim” through lakes taking samples for environmental monitoring. We 
envision a future where biofuel-powered artificial muscles offer an efficient solution for much 
needed silent autonomous propulsion in soft microrobots, ingestible devices and implantable 
artificial muscles.  
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Figure 1. Working principles of a trilayer artificial muscle and bioelectrodes. (A) 
Schematic description of the functioning of a ‘trilayer’ conducting polymer actuator or 
artificial muscle. (B) Schematic description of the bioelectrode pair producing electricity to 
power e.g. artificial muscles.  
  
 
Figure 2. Bioelectrode characterization. (A) Polarization curves of modified electrodes. (a) 
The GOx/TTF-TCNQ-modified Au electrode (curve a) and (b) the laccase/ABTS-modified Au 
electrode (curve b). (B) Dependence the OCP of the bioelectrode pair on time. (C) The 
dependence of power density on the voltage of the bioanode TTF-TCNQ/GOx and biocathode 
ABTS/laccase pair in 0.1 M PBS (pH 5.0) with an air-saturated solution and 0.1 M of glucose. 






Figure 3. Proof of principle an artificial muscle driven by an external bioelectrode pair. 
Movement of the PPy/Au/PVDF/Au/PPy trilayer artificial muscle driven by the external 
bioelectrodes. T0 is the initial position when connecting the bioelectrode pair to the actuator 
and T1 is the final position after 4 h showing that the bioelectrodes have powered the artificial 
muscle causing it to bend towards the anode side with a 5 mm displacement. (The image is 








Figure 4. Bioelectrode integrated artificial muscles. (A) The movement of the 
PPy/Au/PVDF/Au/PPy with two separated bioelectrodes integrated on the top. T0 initial 
position of artificial muscle and T1 position after 3 hours, showing a 2 mm displacement. (B) 
The movement of the artificial muscle with the fully integrated bioelectrodes. T0 is starting 
position and T1 the position after 3 hours. The actuator moved 3 mm to the anode side. (see 
videos in SI) (C) The displacement versus time of the actuator with fully integrated 
bioelectrodes of (B).  
  
 
   
 
Figure 5. Artificial muscle with double bioelectrode pair to simulate on/off switching. (A) 
The artificial muscle is inserted into the electrolyte with only one bioelectrode pair submerged. 
The actuator bent towards the left, the anode side for 2.5 mm, from T0 to T1, after 3 hours. (B) 
Next, the actuator was rotated, and the other electrode pair was submerged. The artificial 
muscle now bent back to the right, towards the anode, which was the former cathode position, 
from T2 to T3, again after 3 hours. 
 
 
